Page last updated: 2024-08-16

tibolone and raloxifene hydrochloride

tibolone has been researched along with raloxifene hydrochloride in 67 studies

Research

Studies (67)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (1.49)	18.2507
2000's	52 (77.61)	29.6817
2010's	13 (19.40)	24.3611
2020's	1 (1.49)	2.80

Authors

Authors	Studies
Christiansen, C	1
von Holst, T	1
Ciaponi, M; Gambacciani, M	1
Galid, A; Kubista, E; Seifert, M	1
Birkhäuser, MH	1
Godsland, IF	1
Berendsen, HH; Kloosterboer, HJ; Weekers, AH	1
Ang, WC; Farrell, E; Vollenhoven, B	1
Baker, RS; Clark, KE; Kopernik, G; Mershon, JL; Zoma, WD	1
Ascaso, C; Casals, E; Castelo-Branco, C; Colodrón, M; Escaramís, G; Mercadé, I; Ordi, J; Sanjuán, A; Vanrell, JA; Vicente, JJ	1
Kourtis, A; Kukuvitis, A; Makedos, G; Panidis, D; Papaiconomou, N; Zournatzi, V	1
Chondros, C; Christodoulakos, G; Creatsas, G; Lambrinoudaki, I; Panoulis, C; Patramanis, P	1
Lakatos, P	1
Mueck, AO; Seeger, H	1
László, A	1
Alexandrou, A; Christodoulakos, G; Creatsas, G; Lambrinoudaki, I; Liakakos, T; Panoulis, C; Papadias, C; Sarandakou, A	1
Christodoulakos, GE; Creatsas, GC; Kouskouni, EE; Lambrinoudaki, IV; Panoulis, CP; Papadias, CA	1
Ager, FJ; Gómez-Zubelbia, MA; Millán, JC; Pinheiro, T; Ynsa, MD	1
Boisserie-Lacroix, M; Boutet, G; Trillaud, H	1
Mijatovic, V; van der Mooren, MJ; Vogelvang, TE	1
Botsis, D; Caramalis, G; Christodoulakos, G; Creatsas, G; Lambrinoudaki, I; Panoulis, C; Rizos, D; Sioulas, V	1
Czerny, B; Juzyszyn, Z; Myśliwiec, Z; Pawlik, A; Teister, M	1
Celik, O; Erdem, G; Hascalik, S; Karakas, HM; Tamser, M	1
Cheifitz, RL	1
Bjarnason, NH	1
Celik, O; Hascalik, S; Mizrak, B; Tamser, M	1
Herrington, DM; Lakoski, SG	1
Alexandrou, AP; Augoulea, AD; Botsis, DS; Christodoulakos, GE; Creatsa, MG; Creatsas, GC; Dendrinos, SG; Lambrinoudaki, IV; Panoulis, CP; Papagianni, VD	1
Aravantinos, L; Botsis, D; Christodoulakos, G; Creatsas, G; Lambrinoudaki, I; Makrakis, E; Papagianni, V	1
Franke, HR; Vermes, I; Werner, HM	1
Andersen, TO; Eilertsen, AL; Qvigstad, E; Sandset, PM; Sandvik, L	1
Christodoulakos, GE; Creatsas, GC; Economou, EV; Kouskouni, EE; Lambrinoudaki, IV; Panoulis, CP; Papadias, C; Vitoratos, N; Vlachou, SA	1
Archer, DF; Mirkin, S; Wong, BC	1
Andersen, TO; Eilertsen, AL; Mowinckel, MC; Qvigstad, E; Sandset, PM; Sandvik, L	1
Eilertsen, AL; Hemker, HC; Liestøl, S; Mowinckel, MC; Sandset, PM	1
Abildgaard, U; Andresen, MS; Eilertsen, AL; Sandset, PM	1
Christodoulakos, G; Creatsas, G; Lambrinoudaki, I; Politi, E; Sergentanis, TN; Sioulas, V	1
Abaurrea Ortiz, MP; Caballero Carrasco, A; Pérez García, VJ; Rangel Tarifa, MJ	1
Davis, SR; Nijland, EA; Weijmar Schultz, WC	1
Kluft, C	1
Lethaby, AE; Vollenhoven, BJ	1
Alexandrou, AP; Christodoulakos, GE; Creatsas, GC; Economou, EV; Kouskouni, EE; Lambrinoudaki, IV; Panoulis, CP; Vlachou, SA	1
Bayram, M; Kabakci, N; Kalender, H; Kisa, U; Ozer, G; Ozkan, Y	1
Adami, S; Davis, SR; Delmas, PD; Hensen, J; Nijland, EA; van Os, S	1
Eilertsen, AL; Karssemeijer, N; Qvigstad, E; Sandset, PM; Skaane, P	1
Christodoulakos, GE; Creatsa, MG; Economou, EV; Kalligerou, I; Lambrinoudaki, IV; Panoulis, CP; Papadias, C; Siasou, Z	1
Eilertsen, AL; Sandset, PM; Sandvik, L; Steinsvik, B	1
Wu, J; Zhu, Y	1
Neves-E-Castro, M	1
Bruce, D; Frick, A; Robinson, J; Rymer, J; Ylikorkala, O	1
Cetin, A; Cetin, M; Durna, A; Erden, O; Guvenal, F; Guvenal, T	1
Fu, R; Griffin, JC; Humphrey, L; Nelson, HD; Nygren, P; Smith, ME	1
Arun, B; Brown, PH; Castiglione, M; Cuzick, J; DeCensi, A; Dunn, B; Forbes, JF; Glaus, A; Howell, A; Vogel, V; von Minckwitz, G; Zwierzina, H	1
Jacobsen, DE; Melis, RJ; Olde Rikkert, MG; Verhaar, HJ	1
Aravantinos, L; Augoulea, A; Creatsa, M; Kyroudi, A; Lambrinoudaki, I; Panoulis, C; Politi, E; Rizos, D; Sergentanis, TN; Sioulas, VD	1
Dahm, AE; Eilertsen, AL; Goeman, J; Kierulf, P; Mowinckel, MC; Olstad, OK; Ovstebø, R; Sandset, PM; Skretting, G	1
McLaren, JS; Morris, E; Rymer, J	1
Alexandrou, A; Aravantinos, L; Augoulea, A; Creatsa, M; Kaparos, G; Karaflou, M; Kouskouni, E; Lambrinoudaki, I	1
Eyster, KM; Hansen, KA	1
Ferriani, RA; Figueiredo, JB; Lara, LA; Martins, WP; Nastri, CO; Rosa-E-Silva, AC	1
Akercan, F; Akin, M; Akman, L; Duygu, H; Ozerkan, F; Ulukus, M	1
Brito, LG; Candido Dos Reis, FJ; Ferriani, RA; Martins, WP; Moroni, RM; Nastri, CO; Vieira, CS	1
Briarava, M; Mocellin, S; Nitti, D; Pilati, P	1
Dahm, AEA; Eilertsen, AL; Høibraaten, E; Lofthus, CM; Mowinckel, MC; Sandset, PM	1
Black, DM; Cheung, AM; Eastell, R; Murad, MH; Rosen, CJ; Shoback, D	1
Elgebaly, Z; Elliott, J; Naik-Panvelkar, P; Norman, S; Pollack, A; Seibel, MJ; Thistlethwaite, J; Weston, C	1

Reviews

21 review(s) available for tibolone and raloxifene hydrochloride

Article	Year
[Alternatives to hormone replacement therapy: raloxifene and tibolone]. Zeitschrift fur arztliche Fortbildung und Qualitatssicherung, 2000, Volume: 94, Issue:3 Topics: Antihypertensive Agents; Bone Density; Climacteric; Estrogen Replacement Therapy; Female; Humans; Norpregnenes; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride	2000
Postmenopausal osteoporosis management. Current opinion in obstetrics & gynecology, 2000, Volume: 12, Issue:3 Topics: Bone Density; Female; Hormone Replacement Therapy; Humans; Norpregnenes; Osteoporosis, Postmenopausal; Radiography; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Ultrasonography; Women's Health	2000
[Indications for hormone replacement therapy]. Therapeutische Umschau. Revue therapeutique, 2000, Volume: 57, Issue:10 Topics: Aged; Alzheimer Disease; Anabolic Agents; Breast Neoplasms; Cardiovascular Diseases; Contraindications; Endometrial Neoplasms; Estrogen Replacement Therapy; Estrogens; Female; Humans; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal; Postmenopause; Progestins; Raloxifene Hydrochloride; Risk; Selective Estrogen Receptor Modulators; Thrombosis	2000
Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: analysis of studies published from 1974-2000. Fertility and sterility, 2001, Volume: 75, Issue:5 Topics: Anabolic Agents; Apolipoproteins; Apoprotein(a); Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Estradiol; Estrogen Replacement Therapy; Estrogens; Female; Humans; Lipoprotein(a); Middle Aged; Norpregnenes; Progestins; Prospective Studies; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Triglycerides	2001
Effect of hormone replacement therapies and selective estrogen receptor modulators in postmenopausal women with uterine leiomyomas: a literature review. Climacteric : the journal of the International Menopause Society, 2001, Volume: 4, Issue:4 Topics: Animals; Disease Models, Animal; Estrogen Replacement Therapy; Female; Humans; Leiomyoma; Norpregnenes; Postmenopause; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Tamoxifen; Uterine Neoplasms	2001
[Treatment of osteoporosis]. Orvosi hetilap, 2003, Aug-03, Volume: 144, Issue:31 Topics: Bone Density; Calcitonin; Calcium Compounds; Diphosphonates; Estrogen Replacement Therapy; Female; Humans; Male; Norpregnenes; Osteoporosis; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Vitamin D	2003
Hormone therapy after endometrial cancer. The journal of the British Menopause Society, 2003, Volume: 9, Issue:4 Topics: Age Distribution; Aged; Chemotherapy, Adjuvant; Cyclohexanols; Dose-Response Relationship, Drug; Drug Administration Schedule; Endometrial Neoplasms; Estrogens; Female; Germany; Hormone Replacement Therapy; Humans; Hysterectomy; Incidence; Middle Aged; Neoplasm Staging; Norpregnenes; Progestins; Raloxifene Hydrochloride; Risk Assessment; Survival Analysis; Treatment Outcome; Venlafaxine Hydrochloride	2003
[Postmenopausal osteoporosis]. Orvosi hetilap, 2004, Jan-04, Volume: 145, Issue:1 Topics: Absorptiometry, Photon; Anabolic Agents; Calcitonin; Calcium, Dietary; Diphosphonates; Estrogen Replacement Therapy; Female; Fractures, Bone; Humans; Isoflavones; Motor Activity; Norpregnenes; Osteoporosis, Postmenopausal; Phytoestrogens; Plant Preparations; Raloxifene Hydrochloride; Risk Factors; Selective Estrogen Receptor Modulators; Vitamin D; Weight-Bearing	2004
[Menopausal hormonal therapies: impact on mammographic breast density]. Journal de radiologie, 2004, Volume: 85, Issue:10 Pt 1 Topics: Breast; Breast Neoplasms; Estrogen Receptor Modulators; Female; Hormone Replacement Therapy; Humans; Mammography; Mass Screening; Menopause; Norpregnenes; Raloxifene Hydrochloride	2004
Hormone replacement therapy, selective estrogen receptor modulators, and tissue-specific compounds: cardiovascular effects and clinical implications. Treatments in endocrinology, 2004, Volume: 3, Issue:2 Topics: Aging; Animals; Arteriosclerosis; Cardiovascular Diseases; Cardiovascular System; Estrogen Replacement Therapy; Female; Humans; Menopause; Middle Aged; Norpregnenes; Postmenopause; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Tamoxifen	2004
Hormone replacement therapy--differing guidelines. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 2005, Volume: 95, Issue:4 Topics: Contraindications; Estrogen Receptor Modulators; Female; Hormone Replacement Therapy; Humans; Menopause; Norpregnenes; Practice Guidelines as Topic; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Treatment Outcome	2005
Effects of oestrogen receptor-active compounds on lipid metabolism. Diabetes, obesity & metabolism, 2005, Volume: 7, Issue:5 Topics: Antineoplastic Agents; Bone Density Conservation Agents; Female; Humans; Lipid Metabolism; Male; Norpregnenes; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tamoxifen	2005
Effects of hormone treatment on hemostasis variables. Climacteric : the journal of the International Menopause Society, 2007, Volume: 10 Suppl 2 Topics: Administration, Oral; Administration, Topical; Dose-Response Relationship, Drug; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Ethinyl Estradiol; Female; Hemostasis; Humans; Inflammation; Norpregnenes; Progestins; Raloxifene Hydrochloride; Tamoxifen; Venous Thromboembolism	2007
An evidence-based approach to hormonal therapies for premenopausal women with fibroids. Best practice & research. Clinical obstetrics & gynaecology, 2008, Volume: 22, Issue:2 Topics: Antineoplastic Agents, Hormonal; Drug Therapy, Combination; Estrogen Antagonists; Evidence-Based Medicine; Female; Gonadotropin-Releasing Hormone; Humans; Leiomyoma; Norpregnenes; Premenopause; Progestins; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Uterine Neoplasms	2008
Association of ovarian and uterine cancers with postmenopausal hormonal treatments. Clinical obstetrics and gynecology, 2008, Volume: 51, Issue:3 Topics: Estrogen Replacement Therapy; Estrogens; Female; Humans; Norpregnenes; Ovarian Neoplasms; Postmenopause; Progestins; Raloxifene Hydrochloride; Risk Factors; Tamoxifen; Uterine Neoplasms	2008
Systematic review: comparative effectiveness of medications to reduce risk for primary breast cancer. Annals of internal medicine, 2009, Nov-17, Volume: 151, Issue:10 Topics: Breast Neoplasms; Endometrial Neoplasms; Estrogen Receptor Modulators; Female; Fractures, Bone; Humans; Norpregnenes; Raloxifene Hydrochloride; Stroke; Tamoxifen; Thromboembolism	2009
Preventive therapy for breast cancer: a consensus statement. The Lancet. Oncology, 2011, Volume: 12, Issue:5 Topics: Anastrozole; Androstadienes; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Consensus Development Conferences as Topic; Diphosphonates; Estrogen Receptor Modulators; Expert Testimony; Female; Fenretinide; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Metformin; Nitriles; Norpregnenes; Piperidines; Premenopause; Pyrrolidines; Raloxifene Hydrochloride; Retinoids; Selective Estrogen Receptor Modulators; Tamoxifen; Tetrahydronaphthalenes; Thiophenes; Triazoles	2011
Gonadotrophin receptor hormone analogues in combination with add-back therapy: an update. Menopause international, 2012, Volume: 18, Issue:2 Topics: Bone Density; Bone Density Conservation Agents; Calcitonin; Diphosphonates; Endometriosis; Estrogen Antagonists; Estrogen Receptor Modulators; Female; Gonadotropin-Releasing Hormone; Hormone Replacement Therapy; Humans; Leiomyoma; Lipids; Menstruation Disturbances; Norpregnenes; Parathyroid Hormone; Premenstrual Syndrome; Raloxifene Hydrochloride; Uterine Diseases; Vitamin D	2012
Hormone therapy for sexual function in perimenopausal and postmenopausal women. The Cochrane database of systematic reviews, 2013, Jun-05, Issue:6 Topics: Drug Therapy, Combination; Estrogens; Female; Humans; Indoles; Middle Aged; Norpregnenes; Perimenopause; Postmenopause; Progesterone; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Selective Estrogen Receptor Modulators; Sexual Dysfunction, Physiological	2013
Add-back therapy with GnRH analogues for uterine fibroids. The Cochrane database of systematic reviews, 2015, Mar-20, Issue:3 Topics: Antineoplastic Agents, Hormonal; Bone Density; Bone Density Conservation Agents; Drug Therapy, Combination; Estriol; Female; Gonadotropin-Releasing Hormone; Humans; Isoflavones; Leiomyoma; Medroxyprogesterone; Norpregnenes; Quality of Life; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Uterine Hemorrhage; Uterine Neoplasms	2015
Breast Cancer Chemoprevention: A Network Meta-Analysis of Randomized Controlled Trials. Journal of the National Cancer Institute, 2016, Volume: 108, Issue:2 Topics: Adult; Aged; Anticarcinogenic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; Middle Aged; Norpregnenes; Piperidines; Postmenopause; Primary Prevention; Pyrrolidines; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Risk Assessment; Selective Estrogen Receptor Modulators; Tamoxifen; Tetrahydronaphthalenes; Thiophenes	2016

Trials

22 trial(s) available for tibolone and raloxifene hydrochloride

Article	Year
Differential effects of unopposed versus opposed hormone therapy, tibolone, and raloxifene on substance p levels. Fertility and sterility, 2003, Volume: 80, Issue:1 Topics: Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Progesterone Congeners; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Substance P	2003
Effect of hormone therapy, tibolone and raloxifene on circulating vascular endothelial growth factor in Greek postmenopausal women. European journal of endocrinology, 2004, Volume: 151, Issue:2 Topics: Estrogen Antagonists; Estrogen Replacement Therapy; Estrogens; Female; Greece; Humans; Medroxyprogesterone; Middle Aged; Norpregnenes; Postmenopause; Prospective Studies; Raloxifene Hydrochloride; Vascular Endothelial Growth Factor A	2004
Effect of hormone replacement therapy, tibolone and raloxifene on serum lipids, apolipoprotein A1, apolipoprotein B and lipoprotein(a) in Greek postmenopausal women. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2004, Volume: 18, Issue:5 Topics: Adult; Aged; Apolipoprotein A-I; Apolipoproteins; Apolipoproteins B; Cholesterol; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Greece; Humans; Lipids; Lipoprotein(a); Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norpregnenes; Postmenopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Triglycerides	2004
The effect of raloxifene and tibolone on the uterine blood flow and endometrial thickness: a transvaginal Doppler study. Maturitas, 2006, Feb-20, Volume: 53, Issue:3 Topics: Arteries; Endometrium; Estrogen Antagonists; Estrogen Receptor Modulators; Female; Follow-Up Studies; Humans; Middle Aged; Norpregnenes; Prospective Studies; Pulsatile Flow; Raloxifene Hydrochloride; Regional Blood Flow; Ultrasonography, Doppler; Uterus; Vascular Resistance	2006
Conventional-dose hormone therapy (HT) and tibolone, but not low-dose HT and raloxifene, increase markers of activated coagulation. Maturitas, 2006, Oct-20, Volume: 55, Issue:3 Topics: Antineoplastic Agents, Hormonal; Blood Coagulation; Blood Coagulation Tests; Bone Density Conservation Agents; Drug Therapy, Combination; Estradiol; Female; Hormone Replacement Therapy; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Raloxifene Hydrochloride; Thromboembolism	2006
Circulating chemoattractants RANTES, negatively related to endogenous androgens, and MCP-1 are differentially suppressed by hormone therapy and raloxifene. Atherosclerosis, 2007, Volume: 193, Issue:1 Topics: Adult; Androgens; Atherosclerosis; Biomarkers; Cardiovascular System; Chemokine CCL2; Chemokine CCL5; Chemotaxis; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators	2007
Differential effects of conventional and low dose oral hormone therapy (HT), tibolone, and raloxifene on coagulation and fibrinolysis. Thrombosis research, 2007, Volume: 120, Issue:3 Topics: Administration, Oral; Aged; Blood Coagulation; Dose-Response Relationship, Drug; Drug Combinations; Estradiol; Estrogen Receptor Modulators; Female; Fibrinolysis; Hormone Replacement Therapy; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Raloxifene Hydrochloride; Retrospective Studies; Time Factors	2007
Differential impact of conventional and low-dose oral hormone therapy (HT), tibolone and raloxifene on functionality of the activated protein C system. Thrombosis and haemostasis, 2007, Volume: 97, Issue:6 Topics: Activated Protein C Resistance; Administration, Oral; Blood Coagulation; Dose-Response Relationship, Drug; Drug Combinations; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Protein C; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tablets; Thromboembolism; Treatment Outcome; Venous Thrombosis	2007
Hormone therapy and raloxifene reduce the coagulation inhibitor potential. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2007, Volume: 18, Issue:5 Topics: Aged; Blood Coagulation; Estrogen Antagonists; Estrogen Replacement Therapy; Factor V; Female; Fibrin; Heterozygote; Humans; Middle Aged; Mutation; Norpregnenes; Postmenopause; Raloxifene Hydrochloride; Risk Factors; Thrombophilia; Venous Thromboembolism	2007
Effects of tibolone and raloxifene on health-related quality of life and sexual function. Maturitas, 2007, Oct-20, Volume: 58, Issue:2 Topics: Aged; Double-Blind Method; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Europe; Female; Humans; Middle Aged; Norpregnenes; Postmenopause; Quality of Life; Raloxifene Hydrochloride; Sexuality; Surveys and Questionnaires; Treatment Outcome; United States; Vaginal Diseases	2007
Circulating leptin and ghrelin are differentially influenced by estrogen/progestin therapy and raloxifene. Maturitas, 2008, Jan-20, Volume: 59, Issue:1 Topics: Adult; Body Mass Index; Contraceptives, Oral, Synthetic; Estradiol; Estrogen Receptor Modulators; Estrogens; Estrogens, Conjugated (USP); Fas Ligand Protein; Female; Follicle Stimulating Hormone; Ghrelin; Hormone Replacement Therapy; Humans; Insulin; Leptin; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Raloxifene Hydrochloride; Sex Hormone-Binding Globulin	2008
Effects of tibolone and raloxifene on bone mineral density in osteopenic postmenopausal women. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2008, Volume: 19, Issue:8 Topics: Aged; Biomarkers; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Bone Remodeling; Collagen Type I; Double-Blind Method; Female; Hip Joint; Humans; Lumbar Vertebrae; Middle Aged; Norpregnenes; Osteocalcin; Osteoporosis, Postmenopausal; Peptides; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators	2008
Differential impact of conventional and low-dose oral hormone therapy, tibolone and raloxifene on mammographic breast density, assessed by an automated quantitative method. BJOG : an international journal of obstetrics and gynaecology, 2008, Volume: 115, Issue:6 Topics: Administration, Oral; Aged; Breast; Contraceptives, Oral, Synthetic; Drug Combinations; Estradiol; Estrogen Receptor Modulators; Estrogens; Female; Hormone Replacement Therapy; Humans; Mammography; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Organ Size; Postmenopause; Raloxifene Hydrochloride	2008
Circulating levels of atherogenesis-associated adipocytokines and apoptotic markers are differentially influenced by hormone therapy, tibolone and raloxifene in healthy postmenopausal women. Climacteric : the journal of the International Menopause Society, 2008, Volume: 11, Issue:2 Topics: Adipokines; Adiponectin; Adult; Apoptosis; Atherosclerosis; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Fas Ligand Protein; fas Receptor; Female; Greece; Humans; Lipids; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Postmenopause; Raloxifene Hydrochloride; Resistin; Selective Estrogen Receptor Modulators	2008
Differential impact of conventional-dose and low-dose postmenopausal hormone therapy, tibolone and raloxifene on C-reactive protein and other inflammatory markers. Journal of thrombosis and haemostasis : JTH, 2008, Volume: 6, Issue:6 Topics: Aged; Antineoplastic Agents, Hormonal; Biomarkers; Bone Density Conservation Agents; C-Reactive Protein; Cell Adhesion; Estrogen Replacement Therapy; Female; Humans; Inflammation; Middle Aged; Norpregnenes; Postmenopause; Raloxifene Hydrochloride	2008
A comparison of hormone therapies on the urinary excretion of prostacyclin and thromboxane A2. Climacteric : the journal of the International Menopause Society, 2008, Volume: 11, Issue:6 Topics: Cardiovascular Diseases; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Epoprostenol; Estradiol; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Raloxifene Hydrochloride; Thromboxane A2	2008
Effects of different postmenopausal hormone therapy regimens on cerebral blood flow and cognitive functions. Advances in therapy, 2009, Volume: 26, Issue:8 Topics: Adult; Analysis of Variance; Blood Flow Velocity; Cerebrovascular Circulation; Chi-Square Distribution; Cognition; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Follow-Up Studies; Humans; Medroxyprogesterone Acetate; Mental Status Schedule; Middle Aged; Norpregnenes; Postmenopause; Raloxifene Hydrochloride; Turkey; Ultrasonography, Doppler, Transcranial	2009
Raloxifene and tibolone in elderly women: a randomized, double-blind, double-dummy, placebo-controlled trial. Journal of the American Medical Directors Association, 2012, Volume: 13, Issue:2 Topics: Absorptiometry, Photon; Academic Medical Centers; Age Factors; Aged; Aged, 80 and over; Body Mass Index; Bone Density; Bone Density Conservation Agents; Confidence Intervals; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug-Related Side Effects and Adverse Reactions; Estrogen Receptor Modulators; Female; Follow-Up Studies; Humans; Middle Aged; Netherlands; Norpregnenes; Osteoporosis, Postmenopausal; Patient Safety; Raloxifene Hydrochloride; Reference Values; Risk Assessment; Severity of Illness Index; Treatment Outcome	2012
A microarray study on the effect of four hormone therapy regimens on gene transcription in whole blood from healthy postmenopausal women. Thrombosis research, 2012, Volume: 130, Issue:1 Topics: Aged; Drug Combinations; Estradiol; Estrogen Receptor Modulators; Estrogens; Female; Gene Expression Regulation; Hormone Replacement Therapy; Humans; Middle Aged; Norethindrone; Norpregnenes; Postmenopause; Raloxifene Hydrochloride	2012
Effect of tibolone and raloxifene on serum markers of apoptosis in postmenopausal women. Climacteric : the journal of the International Menopause Society, 2013, Volume: 16, Issue:2 Topics: Apoptosis; Biomarkers; Bone Density Conservation Agents; Cytochromes c; Estrogen Receptor Modulators; Fas Ligand Protein; fas Receptor; Female; Humans; Middle Aged; Norpregnenes; Postmenopause; Raloxifene Hydrochloride	2013
The effects of different hormone treatment on endothelial function in healthy postmenopausal women. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2013, Volume: 29, Issue:9 Topics: Adult; Brachial Artery; Drug Combinations; Endothelium, Vascular; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Health; Humans; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Postmenopause; Raloxifene Hydrochloride; Ultrasonography; Vasodilation	2013
Relationship between sex hormone binding globulin and blood coagulation in women on postmenopausal hormone treatment. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2019, Volume: 30, Issue:1 Topics: Activated Protein C Resistance; Blood Coagulation; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norpregnenes; Postmenopause; Raloxifene Hydrochloride; Sex Hormone-Binding Globulin; Venous Thrombosis	2019

Other Studies

24 other study(ies) available for tibolone and raloxifene hydrochloride

Article	Year
Sex steroid analogs. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 1999, Volume: 9 Suppl 2 Topics: Animals; Bone Resorption; Breast Neoplasms; Estrogen Antagonists; Female; Gonadal Steroid Hormones; Hormones; Humans; Norpregnenes; Osteoporosis, Postmenopausal; Pyrrolidines; Raloxifene Hydrochloride; Receptors, Estrogen; Risk; Tamoxifen	1999
The oestrogen receptor and its selective modulators in gynaecological oncology. European journal of cancer (Oxford, England : 1990), 2000, Volume: 36 Suppl 4 Topics: Antineoplastic Agents, Hormonal; Cinnamates; Estrogen Antagonists; Female; Genital Neoplasms, Female; Humans; Norpregnenes; Piperidines; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Stilbenes; Tamoxifen; Thiophenes; Toremifene	2000
Effect of tibolone and raloxifene on the tail temperature of oestrogen-deficient rats. European journal of pharmacology, 2001, May-04, Volume: 419, Issue:1 Topics: Adrenergic alpha-Agonists; Anabolic Agents; Animals; Body Temperature; Clonidine; Dose-Response Relationship, Drug; Estradiol; Estrogens; Female; Hot Flashes; Humans; Motor Activity; Norpregnenes; Ovariectomy; Raloxifene Hydrochloride; Rats; Rats, Wistar; Selective Estrogen Receptor Modulators; Tail	2001
Menopause. HRT: looking for something better. Harvard health letter, 2002, Volume: 27, Issue:7 Topics: Breast Neoplasms; Estrogen Replacement Therapy; Female; Humans; Myocardial Infarction; Norpregnenes; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators	2002
Differential effects of selective estrogen receptor modulators and estrogens on mammary blood flow in the ovine. American journal of obstetrics and gynecology, 2002, Volume: 187, Issue:6 Topics: Animals; Blood Flow Velocity; Blood Pressure; Estradiol; Estrogens; Estrogens, Conjugated (USP); Female; Heart Rate; Kinetics; Mammary Glands, Animal; Norpregnenes; Ovariectomy; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Sheep; Tamoxifen	2002
Effects of estradiol, cyproterone acetate, tibolone and raloxifene on uterus and aorta atherosclerosis in oophorectomized cholesterol-fed rabbits. Maturitas, 2003, May-30, Volume: 45, Issue:1 Topics: Animals; Aorta; Arteriosclerosis; Cholesterol, Dietary; Cyproterone Acetate; Disease Models, Animal; Estradiol; Estrogen Replacement Therapy; Female; Norpregnenes; Ovariectomy; Rabbits; Raloxifene Hydrochloride; Uterus	2003
Serum lipids and apolipoproteins in Greek postmenopausal women: association with estrogen, estrogen-progestin, tibolone and raloxifene therapy. Journal of endocrinological investigation, 2003, Volume: 26, Issue:6 Topics: Apolipoproteins; Cross-Sectional Studies; Drug Therapy, Combination; Estrogen Receptor Modulators; Estrogens; Female; Greece; Humans; Lipids; Middle Aged; Norpregnenes; Progestins; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators	2003
Effect of hormone replacement therapy on the elemental contents of uterine tissue. Biological trace element research, 2004, Volume: 101, Issue:1 Topics: Animals; Estrogens; Female; Hormone Replacement Therapy; Norpregnenes; Progesterone; Raloxifene Hydrochloride; Rats; Selective Estrogen Receptor Modulators; Trace Elements; Uterus	2004
Serum androgen levels and insulin resistance in postmenopausal women: association with hormone therapy, tibolone and raloxifene. Maturitas, 2005, Apr-11, Volume: 50, Issue:4 Topics: Adult; Aged; Androgens; Cross-Sectional Studies; Dehydroepiandrosterone Sulfate; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Insulin; Insulin Resistance; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Sex Hormone-Binding Globulin; Testosterone	2005
Effect of tamoxifen, raloxifen and tibolon on bile components in ovariectomized rats. European journal of obstetrics, gynecology, and reproductive biology, 2005, Apr-01, Volume: 119, Issue:2 Topics: Animals; Bile; Bile Acids and Salts; Calcium; Chlorides; Cholesterol; Female; Norpregnenes; Ovariectomy; Raloxifene Hydrochloride; Rats; Rats, Wistar; Tamoxifen	2005
Magnetic resonance spectroscopic comparison of the effects of resveratrol (3,4',5-trihydroxy stilbene) to conjugated equine estrogen, tibolone and raloxifene on ovariectomized rat brains. European journal of obstetrics, gynecology, and reproductive biology, 2005, May-01, Volume: 120, Issue:1 Topics: Animals; Aspartic Acid; Brain; Brain Chemistry; Choline; Creatine; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Magnetic Resonance Spectroscopy; Norpregnenes; Ovariectomy; Raloxifene Hydrochloride; Rats; Rats, Wistar; Resveratrol; Stilbenes	2005
Differential effects of alternatives to hormone replacement therapy in postmenopausal healthy women. Danish medical bulletin, 2005, Volume: 52, Issue:2 Topics: Animals; Atherosclerosis; Bone and Bones; Cardiovascular System; Estrogen Replacement Therapy; Estrogens; Female; Humans; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal; Postmenopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators	2005
Effects of resveratrol, raloxifene, tibolone and conjugated equine estrogen on vaginal squamous cell maturation of ovariectomized rats. Gynecologic and obstetric investigation, 2005, Volume: 60, Issue:4 Topics: Animals; Epithelial Cells; Estrogens, Conjugated (USP); Female; Norpregnenes; Ovariectomy; Ovary; Papanicolaou Test; Raloxifene Hydrochloride; Rats; Rats, Wistar; Resveratrol; Stilbenes; Vagina; Vaginal Smears	2005
A 5-year study on the effect of hormone therapy, tibolone and raloxifene on vaginal bleeding and endometrial thickness. Maturitas, 2006, Mar-20, Volume: 53, Issue:4 Topics: Aged; Endometrium; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Follicle Stimulating Hormone; Humans; Metrorrhagia; Middle Aged; Norpregnenes; Patient Dropouts; Postmenopause; Prospective Studies; Raloxifene Hydrochloride; Statistics as Topic	2006
Apoptosis and proliferation in breast cancer cells, cultured in vitro: effects of SERMs. Climacteric : the journal of the International Menopause Society, 2005, Volume: 8, Issue:3 Topics: Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Contraceptive Agents, Female; Dydrogesterone; Estradiol; Estrogen Replacement Therapy; Humans; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Norpregnenes; Progesterone; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tamoxifen; Tumor Cells, Cultured	2005
Effects of 17beta-estradiol, progesterone, synthetic progestins, tibolone, and raloxifene on vascular endothelial growth factor and Thrombospondin-1 messenger RNA in breast cancer cells. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2006, Volume: 16 Suppl 2 Topics: Breast Neoplasms; Estradiol; Female; Gene Expression Regulation, Neoplastic; Hormones; Humans; Norpregnenes; Progesterone; Progesterone Congeners; Raloxifene Hydrochloride; RNA, Messenger; Thrombospondin 1; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A	2006
E-cadherin expression in cervical epithelial cells of postmenopausal women: association with hormone therapy, tibolone, and raloxifene. Fertility and sterility, 2008, Volume: 89, Issue:4 Topics: Aged; Cadherins; Cervix Uteri; Epithelial Cells; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Humans; Immunohistochemistry; Metaplasia; Middle Aged; Norpregnenes; Papanicolaou Test; Postmenopause; Raloxifene Hydrochloride; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Vaginal Smears	2008
[Review of pharmacological treatment of the menopause]. Atencion primaria, 2007, Volume: 39, Issue:8 Topics: Cross-Over Studies; Drug Prescriptions; Estrogen Replacement Therapy; Female; Humans; Menopause; Middle Aged; Norpregnenes; Primary Health Care; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Spain	2007
The effects of raloxifene and tibolone on homocysteine and vascular histopathological changes. Clinical and experimental medicine, 2007, Volume: 7, Issue:4 Topics: Animals; Atherosclerosis; Carotid Arteries; Estrogen Replacement Therapy; Female; Folic Acid; Homocysteine; Norpregnenes; Raloxifene Hydrochloride; Rats; Rats, Wistar; Vitamin B 12	2007
Effects of estrogen and estrogenic compounds on cognition in ovariectomized rats. Climacteric : the journal of the International Menopause Society, 2008, Volume: 11, Issue:3 Topics: Animals; Cognition; Cognition Disorders; Estradiol; Estrogen Receptor Modulators; Female; Humans; Isoflavones; Maze Learning; Models, Animal; Norpregnenes; Ovariectomy; Postmenopause; Raloxifene Hydrochloride; Random Allocation; Rats; Rats, Sprague-Dawley	2008
Does hormone therapy, tibolone or raloxifene modify VEGF expression in cervical epithelial cells? Climacteric : the journal of the International Menopause Society, 2012, Volume: 15, Issue:2 Topics: Aged; Androstenedione; Cervix Uteri; Contraceptives, Oral, Synthetic; Cross-Sectional Studies; Epithelial Cells; Estradiol; Estrogen Antagonists; Estrogen Receptor Modulators; Estrogens; Female; Humans; Metaplasia; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Papanicolaou Test; Postmenopause; Raloxifene Hydrochloride; Statistics, Nonparametric; Vaginal Smears; Vascular Endothelial Growth Factor A	2012
What happened to WHI: menopausal hormonal therapy in 2012. Clinical obstetrics and gynecology, 2012, Volume: 55, Issue:3 Topics: Atrophy; Breast Neoplasms; Endometrial Neoplasms; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens; Female; Hot Flashes; Humans; Menopause; Middle Aged; Norpregnenes; Patient Selection; Raloxifene Hydrochloride; Vagina	2012
Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society* Clinical Practice Guideline. The Journal of clinical endocrinology and metabolism, 2019, 05-01, Volume: 104, Issue:5 Topics: Absorptiometry, Photon; Accidental Falls; Bone Density Conservation Agents; Calcitonin; Calcium; Clinical Decision-Making; Denosumab; Diphosphonates; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Humans; Norpregnenes; Osteoporosis, Postmenopausal; Osteoporotic Fractures; Parathyroid Hormone-Related Protein; Patient Preference; Raloxifene Hydrochloride; Risk Assessment; Risk Reduction Behavior; Selective Estrogen Receptor Modulators; Teriparatide; Vitamin D	2019
Osteoporosis management in Australian general practice: an analysis of current osteoporosis treatment patterns and gaps in practice. BMC family practice, 2020, 02-12, Volume: 21, Issue:1 Topics: Aged; Aged, 80 and over; Attitude of Health Personnel; Australia; Bone Density Conservation Agents; Denosumab; Deprescriptions; Diphosphonates; Drug Substitution; Female; General Practice; General Practitioners; Humans; Longitudinal Studies; Male; Middle Aged; Norpregnenes; Osteoporosis; Osteoporotic Fractures; Practice Patterns, Physicians'; Raloxifene Hydrochloride; Retrospective Studies; Teriparatide; Thiophenes	2020